Alpha Tau Insight

413 posts

Alpha Tau Insight banner
Alpha Tau Insight

Alpha Tau Insight

@AlphaTauInsight

🧬Insights about the company winning against cancer 📈The potential to save millions & make millions 🤝Unaffiliated with Alpha Tau Medical

เข้าร่วม Mart 2025
98 กำลังติดตาม250 ผู้ติดตาม
ทวีตที่ปักหมุด
Alpha Tau Insight
Alpha Tau Insight@AlphaTauInsight·
🚨WATCH: $DRTS CEO after the stock surges on the Japanese approval news: We’re not looking to raise capital, we’re finishing FDA Phase 3 trial this quarter, Pancreas trial in H1 this year, GBM trial also this year, starting new trials and are forming strategic partnerships.
English
2
11
102
810.4K
Alpha Tau Insight
Alpha Tau Insight@AlphaTauInsight·
Vulvar Cancer Market Size to Grow, as Investments and Personalized Medicine Drive Market Expansion: “Firms are pioneering innovations, such as alpha-radiation cancer therapy, to refine treatment efficacy. Alpha Tau Medical Ltd.'s use of Alpha DaRT therapy underscores the trend towards minimally invasive treatments. The focus on such novel therapies complements the market's trajectory towards non-surgical treatment options.” $DRTS
English
1
0
7
85
Alpha Tau Insight
Alpha Tau Insight@AlphaTauInsight·
@FinnStockinger $DRTS has both the strongest floor and the highest upside, that’s how you pick. Also the most noble mission, potentially saving millions of lives while potentially making you millions of dollars.
English
0
0
6
70
Finn Stockinger
Finn Stockinger@FinnStockinger·
The "Multibagger" List is in. Now, how do we find the REAL winner? You guys delivered some incredible alpha. Here’s a snapshot of the tickers mentioned by the community so far: $NIXX | $FPS | $ATOM | $UAN | $AEHR | $LWLG | $M7U | $LPKF | $IQE | $KULR | $DRTS | $OSS | $SIDU | $SLOIF But let’s be real: Buying everything on this list is a recipe for mediocrity. Diversification is a hedge against ignorance, but concentration is how you build real wealth. If you want a 10x return, you can't just follow the crowd. You need a filter. So, I’m asking you: How do YOU pick the "The One"? What is your personal filter for a 10x play? Or do you have another "dark horse" ticker that belongs on this list? The discussion continues below. Share your process. 👇
Finn Stockinger@FinnStockinger

Time to find the NEXT 10x together. 🚀 Yesterday, I shared my conviction plays: $SATL, $KULR, and $IQE. My strategy is simple: look where the crowd isn’t looking yet. Now, I want to hear from YOU. We have an incredible community of alpha seekers here – let’s use it. Share this post with the entire community, let's do this together! Rules of the game: 1️⃣ Drop your pick for the next multibagger in the comments. 2️⃣ Use $TICKER + a short brief (Why is this an asymmetric play?). 3️⃣ You have 24 hours. What’s next?I will gather all the data, analyze the sentiment, and publish a "Community Alpha Report." The most-voted tickers will get their own deep-dive analysis posts from me. Let’s find the next "hidden gem" before the market wakes up. 💎 Share post to whole communit Start below! 👇

English
11
0
28
4.7K
Alpha Tau Insight รีทวีตแล้ว
Bottleneck Investor
Bottleneck Investor@auer_trist24737·
@FinnStockinger $DRTS 100% response rate across solid tumors (90% of cancers) Also seems to have a positive systemic reaction. The fact that it's not a drug, but a procedure makes approval much less of a hassle. A clinically inferior company was aquired by Merck for 10x DRTS's Market Cap
English
1
1
7
349
Finn Stockinger
Finn Stockinger@FinnStockinger·
Time to find the NEXT 10x together. 🚀 Yesterday, I shared my conviction plays: $SATL, $KULR, and $IQE. My strategy is simple: look where the crowd isn’t looking yet. Now, I want to hear from YOU. We have an incredible community of alpha seekers here – let’s use it. Share this post with the entire community, let's do this together! Rules of the game: 1️⃣ Drop your pick for the next multibagger in the comments. 2️⃣ Use $TICKER + a short brief (Why is this an asymmetric play?). 3️⃣ You have 24 hours. What’s next?I will gather all the data, analyze the sentiment, and publish a "Community Alpha Report." The most-voted tickers will get their own deep-dive analysis posts from me. Let’s find the next "hidden gem" before the market wakes up. 💎 Share post to whole communit Start below! 👇
Finn Stockinger@FinnStockinger

How to find a 10x asymmetric investment? Most people wait for the "perfect" financial report. By then, the 10x move is usually over. I don’t look at the rearview mirror – I look for inflection points. Here are 3 positions from my portfolio where I see massive asymmetry right now: 1️⃣ $SATL (Satellogic) – Vertical Integration & Scaling I entered in January when everyone saw a "slow" space company. What I saw was a founder-led team that finally hit its stride. ➡️The Reality: They delivered crucial contracts in Jan, proving they can execute. ➡️The Vision: They just announced their own constellation and, more importantly, a plan to monetize that data. ➡️My Take: I’m still seeing 10x potential here over the next 2 years as they shift from hardware to high-margin data. 3️⃣ $KULR – The "Safety" Play with a Massive Floor I’ve been accumulating $KULR since last year. They’ve spent years as thermal safety specialists (engineering), but the game changed when they decided to launch their own products. ➡️The Pivot: They are now producing their own batteries for drones, military, and AI storage. They don't make cells - they integrate the best ones (like $AMPX) and make them safe/certified. ➡️The Numbers: Currently scaling from a few thousand to 50,000 units by mid-year (with a path to 100k). ➡️The "Safety Net": They hold over 1,000 BTC in their treasury. With a $100M Market Cap, this provides a massive floor. ➡️My Position: I’m at 3.28 USD average. Currently -25% "in the red," but I’m waiting for the next financial results to double down. 3️⃣ $IQE – The Bottleneck King $IQE has been stuck in low-margin hardware for years. But suddenly, they find themselves at the center of the Photonics & AI revolution. ➡️The Edge: They have a massive, specialized machine park for wafer epitaxy. You can’t just "build" this overnight. ➡️The Result: They went from a boring supplier to one of the biggest bottlenecks in the industry. ➡️My Take: Bought at 19 GBX, already +30% up. I’m holding this patiently because in this market, the bottleneck owner dictates the price. The Lesson? 💡 True asymmetry is about seeing things that aren't in the "standard" indicators yet. It’s about pivots, bottlenecks, and founders who actually deliver. What do you think about these plays? And more importantly - what is YOUR 10x conviction pick for 2026? Let’s talk below. 👇

English
15
2
39
15.9K
Alpha Tau Insight
Alpha Tau Insight@AlphaTauInsight·
@Herbgator67 Sure, they issued a report with a buy rating and 12$ PT for $DRTS on March 23, 2026
Alpha Tau Insight tweet media
English
0
0
1
60
HerbGator
HerbGator@Herbgator67·
@AlphaTauInsight I believe you have previously mentioned claims linking Ladenburg specifically to a $12 PT but no supporting documentation from Ladenburg, research portal, or news wires seem to exist. Can you add clarity please. Thanks
English
1
0
1
48
Alpha Tau Insight
Alpha Tau Insight@AlphaTauInsight·
JUST IN: Alpha Tau (NASDAQ: $DRTS) to advance Pancreatic Cancer trial in Japan. Following the marketing approval for their Alpha DaRT treatment in H&N Cancer, and the amazing results for Pancreatic Cancer in other countries, DRTS is set to start the trial via their Japanese partner Hekabio.
Alpha Tau Insight tweet media
English
0
4
8
223
Alpha Tau Insight
Alpha Tau Insight@AlphaTauInsight·
“On May 2, as part of the session “Pancreatic Cancer I: Diagnosis and Treatment,” the program will include a presentation titled “𝑼𝒑𝒅𝒂𝒕𝒆𝒅 𝑹𝒆𝒔𝒖𝒍𝒕𝒔 𝒐𝒇 𝑭𝒆𝒂𝒔𝒊𝒃𝒊𝒍𝒊𝒕𝒚, 𝑺𝒂𝒇𝒆𝒕𝒚, 𝒂𝒏𝒅 𝑻𝒖𝒎𝒐𝒓 𝑪𝒐𝒏𝒕𝒓𝒐𝒍 𝒊𝒏 𝑻𝒘𝒐 𝑭𝒊𝒓𝒔𝒕 𝒊𝒏 𝑯𝒖𝒎𝒂𝒏 𝑻𝒓𝒊𝒂𝒍𝒔 𝒐𝒇 𝒂 𝑵𝒐𝒗𝒆𝒍 𝑨𝒍𝒑𝒉𝒂 𝑬𝒎𝒊𝒕𝒕𝒊𝒏𝒈 𝑹𝒂𝒅𝒊𝒐𝒏𝒖𝒄𝒍𝒊𝒅𝒆 𝒇𝒐𝒓 𝑷𝒂𝒏𝒄𝒓𝒆𝒂𝒕𝒊𝒄 𝑨𝒅𝒆𝒏𝒐𝒄𝒂𝒓𝒄𝒊𝒏𝒐𝒎𝒂.” On May 3, Alpha Tau will host a very special evening event that includes a cruise and a gala dinner, in which we will provide attendees with a deeper look at our progress and vision. I will also be available together with members of our leadership team throughout the conference.”
English
0
1
1
99
Alpha Tau Insight
Alpha Tau Insight@AlphaTauInsight·
🚨BREAKING: $DRTS to share new Pancreatic Cancer data! After the data shared from the first trial at ASCO GI ignited a 40%+ surge for the stock, now comes the DDW and the CEO just shared they will be presenting data from the second trial along with updated results.
Alpha Tau Insight tweet media
English
4
2
32
143.6K
Alpha Tau Insight
Alpha Tau Insight@AlphaTauInsight·
@FailedHedgie Nicely written! And Ladenburg just gave $DRTS a Buy rating and 12$ Price Target as well. This is a long play, but 2026 is shaping up to be a breakout year for Alpha Tau.
English
0
0
1
99
Alpha Tau Insight รีทวีตแล้ว
Failed Hedgie
Failed Hedgie@FailedHedgie·
One of the themes I've been tracking is the next generation of cancer treatments beyond traditional radiation. There's a small-cap Israeli company developing a unique approach that's been gaining regulatory traction across multiple geographies. $DRTS (Alpha Tau Medical, ~$634M market cap) has developed Alpha DaRT, a targeted alpha-radiation therapy for solid tumors. The news flow here has been impressive -- they just received Japanese marketing approval, have an incredible 5 parallel U.S. clinical trials running (skin, pancreatic, prostate, glioblastoma, and more), and their New Hampshire manufacturing facility just got licensed with capacity for 400,000 Alpha DaRT sources. Cash sits at $76.9M. Citi raised their target to $9 and HC Wainwright has a $12 Buy. The chart tells a powerful story -- from $2.30 to over $8.60 in the past year. The recent consolidation has been orderly with the ATR contraction at 0.91, meaning daily ranges are tightening up. Volume has been below average, suggesting the consolidation is healthy. The 50-day moving average at $6.76 is well above the 200-day at $5.25. Entry at $7.20, stop at $6.62, target at $9.03 for a 3.2:1 setup. tradingview.com/chart/DRTS/izu… This is not financial advice. These are my personal ideas and transparent thought process.
Failed Hedgie tweet media
English
2
1
5
217
Alpha Tau Insight
Alpha Tau Insight@AlphaTauInsight·
After coming out with a Buy rating for $DRTS, Landenburg added: “We are encouraged by the company's clinical progress and upcoming milestones, especially related to internal organ applications. We expect additional details in the coming months. Finally, the company continues to allocate resources strategically to drive R&D forward. As such, we are reiterating our Buy rating and $12 price target.”
English
0
1
3
391
Alpha Tau Insight
Alpha Tau Insight@AlphaTauInsight·
Ladenburg Thalmann rates $DRTS as a Buy with a Price Target of 12$. The Investment Bank sees Alpha Tau “Maintaining Momentum with Multiple Clinical Milestones Expected Throughout 2026.” They join Citi and H.C. Wainwright as latest firms to set a Buy and raise Price Targets.
Alpha Tau Insight tweet media
English
1
0
7
112.9K
Alpha Tau Insight
Alpha Tau Insight@AlphaTauInsight·
@SidotiResearch The $DRTS presentation was special! The CFO Raphi Levy really brought it to Sidoti with some strong statements
English
0
0
2
73
Sidoti & Company, LLC
Sidoti & Company, LLC@SidotiResearch·
See a recording of these healthcare management teams present at our January conference. $DRTS $TKNO $ELUT $INM $PRE $RHEP $VREX $VMD buff.ly/Tii5TIV
Sidoti & Company, LLC tweet media
English
1
0
3
152
Jones investment📈📊💎
Jones investment📈📊💎@jonestockwatch·
Watchlist Pt. 6 $CXAI $BNAI $DRTS $BBAI $PLUG Watchlist Pt. 7 $EONR $SER $IBO $OCGN $RZLV Watchlist Pt. 8 $TMC $USAR $CRML $SOUN $VCX Watchlist Pt. 9 $SWMR $ALT $NUAI $SERV $GRRR Watchlist Pt. 10 $WNW $UCAR $RR $POLA $YYAI Let's Dominate Tomorrow Bullish
English
1
0
5
971
Alpha Tau Insight
Alpha Tau Insight@AlphaTauInsight·
$DRTS CFO ahead of the several cancer trial readouts expected this year: “Last trial we read out we saw 100% complete response rate, every tumor disappeared of course, and we saw no serious side effects”
English
4
1
28
150K
Alpha Tau Insight
Alpha Tau Insight@AlphaTauInsight·
It’s amazing! And not only does $DRTS work against every solid tumor, it also awakens the immune system and teaches is to fight cancer elsewhere in the body. They have Pancreatic Cancer, GBM and skin trials all reading out this year, as well as more trials including a combination therapy trial with Keytruda.
English
0
0
1
102
Bird
Bird@larry99900·
@AlphaTauInsight It works against every solid tumor, that is great news
English
1
0
1
55